EC Number   |
Application |
Reference |
|---|
   3.2.1.106 | analysis |
contributes to knowledge of N-glycan biosynthesis |
170956 |
| 3.2.1.106 | analysis |
structural analysis of lipid-linked oligosaccharide precursor of asparaginyl oligosaccharides |
-, 170963 |
| 3.2.1.106 | analysis |
using the processing glucosidase activity as latency marker for topological studies with microsomal vesicles from nongluconeogenic tissues in addition to brain and cultured mammalian cells lacking glucose 6-phosphate phosphatase, to assess the intactness of microsomal vesicles |
170958 |
| 3.2.1.106 | medicine |
treatment of Pompe Disease |
694198, 700317 |
| 3.2.1.106 | pharmacology |
enzyme is an inhibitor target for antiviral agents that interfere with the formation of essential glycoproteins required in viral assembly, secretion and infectivity |
170957 |
| 3.2.1.106 | pharmacology |
glucosidase I may be a target for antiviral and antitumor drugs, glucosidase I inhibitors are potentially useful as antiviral, antitumor and antimetastatic agents |
170955, 170956, 170957 |
